$1.32
0.00880.67%
Pre-Market: 4:03 PM EDT
Comments
Loading...
Alzamend Neuro (ALZN) Forecast
NewsEarningsAlzamend Neuro (ALZN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAlzamend Neuro (NASDAQ:ALZN) Stock Quotes, Forecast and News Summary
Alzamend Neuro Stock (NASDAQ: ALZN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alzamend Neuro (ALZN) stock?
You can purchase shares of Alzamend Neuro (NASDAQ:ALZN) through any online brokerage.
Who are Alzamend Neuro (ALZN) competitors?
Other companies in Alzamend Neuro’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Evaxion Biotech (NASDAQ:EVAX), ABVC BioPharma (NASDAQ:ABVC) and Portage Biotech (NASDAQ:PRTG).
What is the forecast, or price target, for Alzamend Neuro (ALZN) stock?
Alzamend Neuro has a consensus price target of $18.25.
What is the current price for Alzamend Neuro (ALZN)?
The stock price for Alzamend Neuro (NASDAQ: ALZN) is $1.3188 last updated November 20, 2024 at 4:03 PM EST.
Does Alzamend Neuro (ALZN) pay a dividend?
There are no upcoming dividends for Alzamend Neuro.
When is Alzamend Neuro (NASDAQ:ALZN) reporting earnings?
Alzamend Neuro’s Q2 earnings are confirmed for Friday, December 13, 2024.
Is Alzamend Neuro (ALZN) going to split?
There is no upcoming split for Alzamend Neuro.
What sector and industry does Alzamend Neuro (ALZN) operate in?
Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.